Andere Kunden interessierten sich auch für
![Handbook of Alginate Based Nano-Structure for Drug Delivery]( "Handbook of Alginate Based Nano-Structure for Drug Delivery")
Handbook of Alginate Based Nano-Structure for Drug Delivery46,99 €![Structure-Based Drug Discovery]( "Structure-Based Drug Discovery")
Structure-Based Drug Discovery106,99 €![Structure-Based Drug Discovery]( "Structure-Based Drug Discovery")
Structure-Based Drug Discovery74,99 €![Design, Synthesis and Evaluation of Small Molecules as ALK5 Inhibitors]( "Design, Synthesis and Evaluation of Small Molecules as ALK5 Inhibitors")
Design, Synthesis and Evaluation of Small Molecules as ALK5 Inhibitors26,99 €![Recent approaches for the design of phosphodiesterase inhibitors]( "Recent approaches for the design of phosphodiesterase inhibitors")
Recent approaches for the design of phosphodiesterase inhibitors36,99 €![Design & Evaluation of Cholinesterase Inhibitors as Antiamnesic Agents]( "Design & Evaluation of Cholinesterase Inhibitors as Antiamnesic Agents")
Design & Evaluation of Cholinesterase Inhibitors as Antiamnesic Agents39,99 €![Structure Activity Relationship of Drugs of Abuse]( "Structure Activity Relationship of Drugs of Abuse")
Structure Activity Relationship of Drugs of Abuse53,99 €
Poly(ADP-ribose)polymerase (PARP) is a chromatin bound nuclear enzyme which gets activated by DNA breaks, uses NAD as substrate and catalyses the poly-ADP ribosylation of a variety of proteins. The enzyme PARP is considered as a suitable target for anti-cancer activity as it is involved in a variety of physiological functions like cellular proliferation, differentiation, apoptosis and DNA replication. Based on the literature, pharmacophoric templates and bio-isosteric replacement approach, quinazolinone and phthalazinone derivatives were selected to design molecules to calculate binding affinity and visualize binding conformations and interactions at the active pocket of target PARP-1 protein. For preliminary evaluation, in silico potential compounds were selected to synthesize, purified by column chromatography, characterized by HNMR and Mass Spectral studies and carried out for in vitro cytotoxicity. Molecular docking and preliminary experimental data helped to investigate Structure Activity Relationship for design of safe and potential PARP-1 inhibitors for cancer therapy.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.